FDG-PET/CT (PET) in the early prediction of benefit from first-line chemotherapy plus bevacizumab (bev) in metastatic colorectal cancer (mCRC).
Lisa Salvatore
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
Chiara Cremolini
No relevant relationships to disclose
Marta Schirripa
No relevant relationships to disclose
Carlotta Antoniotti
No relevant relationships to disclose
Federica Marmorino
No relevant relationships to disclose
Federica Zoratto
No relevant relationships to disclose
Francesca Bergamo
No relevant relationships to disclose
Isa Maura Brunetti
No relevant relationships to disclose
Elisabetta Pfanner
No relevant relationships to disclose
Gianluca Masi
No relevant relationships to disclose
Dario Genovesi
No relevant relationships to disclose
Elena Filidei
No relevant relationships to disclose
Assuero Giorgetti
No relevant relationships to disclose
Alfredo Falcone
No relevant relationships to disclose